Answer
Fractures occurred in 6% of patients treated with Iqirvo (elafibranor), compared with none receiving placebo.
Sources for this answer
- Iqirvo 80 mg film-coated tabletsIpsen Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 1Document updated
Sources checked